John Androsavich

John Androsavich

Company: Pfizer

Job title: Global Head, RNA Emerging Science Lead


Breakfast Panel: Catalyzing the Development & Adoption of Next Generation RNA to Further Advance Their Therapeutic Role 9:30 am

What are the strategies and approaches in place to achieve proof-of-concept and move towards clinical development What is the promise of next-generation RNA therapeutics for the prognosis and diagnosis of different diseases How can we paving the way towards the rapid development and widespread distribution of novel RNA therapeuticsRead more

day: Conference Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.